Mergen.financeCharles River Laboratories International
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sept | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | ▲ 5.5% | ▼ 15.2% | ▼ 3.4% | ▼ 3.2% | ▲ 8.2% | ▲ 25.5% | ▲ 2.5% | ▲ 24.0% | ▲ 2.3% | ▲ 21.8% | ▼ 9.2% | ▲ 63.6% | |
| 2025 | ▲ 12.0% |
From our own closes, each month-end against the previous month-end. Colour saturates at ▲ 24.0%; an empty cell means no data, a dash means we declined to derive one.
Fiscal period: FY · 2025-12-27 (10-K) — annual data, not TTM · USD · Source: SEC EDGAR (public domain)
Balance-sheet lines and ratios (assets, equity, ROE, ROA, net margin, debt/equity) open on the paid plans. See the plans